Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting

Clinica Chimica Acta

Volumn 277, Issue 2, 1998, Pages 191-205

  Martín, Silvia ^a,b   Ladona, Margarita G ^a   Pedro Botet, Juan ^a,b,c   Covas, María I ^a   Rubiés Prat, Juan ^b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

Apo(a) phenotypes; Human apolipoprotein(a) polymorphism; Immunoblotting; Lipoprotein(a); Protein expression; SDS SAGE

Indexed keywords

APOLIPOPROTEIN A; DODECYL SULFATE SODIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; HETEROZYGOTE; HUMAN; IMMUNOBLOTTING; KRINGLE DOMAIN; MALE; MOLECULAR WEIGHT; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SPAIN;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; APOPROTEIN(A); HUMANS; IMMUNOBLOTTING; LIPOPROTEIN(A); MALE; MIDDLE AGED; PHENOTYPE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SEPHAROSE; SODIUM DODECYL SULFATE; SPAIN;

EID: 0031783293     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00126-0     Document Type: Article

References (34)

1. Berg K. A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 1963;59:369-82.
2. McLean JW, Tomlinson JW, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-7.
3. van der Hook YY, Wittekoek ME, Beisiegel U, Kastelein JJ, Koschinsky ML. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably sized isoforms. Hum Mol Genet 1993;2:361-6.
4. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 1993;2:933-40.
5. Fless GM, Rolih CA, Scanu AM. Heterogeneity of human plasma lipoprotein(a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem 1984;259:11470-8.
6. Dahlen GH. Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 1994;108:111-26.
7. Sandkamp M, Funke H, Schulte H, Köhler E, Assmann G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990;36:20-3.
8. Schaefer EJ, Lamon-Fava S, Jenner JL, et al. Lipoprotein(a) levels and risk for coronary heart disease in men: The lipid research clinics coronary primary prevention trial. J Am Med Assoc 1994;271:999-1003.
9. Zenker G, Koltringer P, Boné G, et al. Lipoprotein (a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:942-5.
10. Pedro-Botet J, Sentí M, Nogués X, et al. Lipoprotein (a) and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-62.
11. Tyrrell J, Cooke T, Reilly M, et al. Lipoprotein [Lp(a)] and peripheral vascular disease. J Intern Med 1992;232:349-52.
12. Pedro-Botet J, Sentí M, Auguet T, et al. Apolipoprotein(a) genetic polymorphism and serum lipoprotein(a) concentration in patients with peripheral vascular disease. Atherosclerosis 1993;104:87-94.
13. Utermann G, Duba C, Menzel HJ. Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 1988;78:47-50.
14. Gavish D, Azrolan N, Breslow JL. Plasma Lp(a) concentration is inversely correlated with the ratio of kringle IV/kringle V encoding domains in the apo(a) gene. J Clin Invest 1989;84:2021-7.
15. Gaubatz JW, Ghanem KI, Guevara J, et al. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 1990;31:603-13.
16. Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field electrophoresis. J Clin Invest 1991;87:2153-61.
17. Kraft HG, Kochl S, Menzel HJ, Sandholzer C, Utermann G. The apolipoprotein(a) gene: a transcribed hypervariable locus controlling plasma lipoprotein(a) concentration. Hum Genet 1992;90:220-30.
18. Perombelon YF, Soutar AK, Knight BL. Variation in lipoprotein(a) concentration associated with different apolipoprotein(a) alleles. J Clin Invest 1994;93:1481-92.
19. Boerwinkle F, Menzel HJ, Kraft HG, Utermann G. Genetics of the quantitative Lp(a) lipoprotein trait. llI Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet 1989;82:73-8.
20. Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992;90:52-60.
21. Utermann G, Menzel HJ, Kraft HG, et al. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987;80:458-65.
22. Kamboh MI, Ferrell RE, Kottke BA. Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 1991;49:1063-74.
23. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American blacks and whites. Biochem Biophys Res Commun 1993;191:1192-6.
24. Marcovina SM, Hobbs HH, Albers JJ. Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature. Clin Chem 1996;42:436-9.
25. Konigsberg W. Reduction of disulphide bonds in proteins with dithiothreitol. Meth Enzymol 1972 XXV;13:185-8.
26. Kraft HG, Lingenhel A, Köchl S, et al. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996; 16:713-9.
27. Frazer KA, Narla G, Zhang JL, Rubin EM. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nat Genet 1995;9:424-31.
28. Dieplinger H, Lackner C, Kronenberg F, et al. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993;91:397-401.
29. Auguet T, Sentí M, Rubiés-Prat J, et al. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein(a) genetic polymorphism. Nephrol Dial Transplant 1993;8:1099-103.
30. Suzuki K, Kuriyama M, Saito T, Ichinose A. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 1997;99:1361-6.
31. Rainwater DL, Ludwig MJ, Haffner SM, VandeBerg JL. Lipid and lipoprotein factors associated with variation in Lp(a) density. Arterioscler Thromb Vasc Biol 1995;15:313-9.
32. Geroldi D, Bellotti V, Buscaglia P, et al. Characterization of apo(a) polymorphism by a modified immunoblotting technique in an Italian population. Clin Chim Acta 1993;221:159-69.
33. Valenti K, Aveynier E, Laporte F, Hadjian AJ. Evaluation of the genotyping and phenotyping approaches in the investigation of apolipoprotein (a) size polymorphism. Clin Chim Acta 1997;263:249-60.
34. Jenner JL, Ordovas JM, Lamon-Fava S, et al. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham offspring study. Circulation 1993;87:1135-41.